SASMX
Price
$29.86
Change
+$0.63 (+2.16%)
Updated
Apr 23 closing price
Net Assets
2.04B
VEXRX
Price
$92.56
Change
+$1.44 (+1.58%)
Updated
Apr 23 closing price
Net Assets
19.79B
Ad is loading...

SASMX vs VEXRX

Header iconSASMX vs VEXRX Comparison
Open Charts SASMX vs VEXRXBanner chart's image
ClearBridge Small Cap Growth A
Price$29.86
Change+$0.63 (+2.16%)
VolumeN/A
Net Assets2.04B
Vanguard Explorer Adm
Price$92.56
Change+$1.44 (+1.58%)
VolumeN/A
Net Assets19.79B
SASMX vs VEXRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
SASMX vs. VEXRX commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SASMX is a Buy and VEXRX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VEXRX has more cash in the bank: 19.8B vs. SASMX (2.05B). VEXRX pays higher dividends than SASMX: VEXRX (0.56) vs SASMX (0.00). SASMX was incepted earlier than VEXRX: SASMX (27 years) vs VEXRX (23 years). SASMX (1.18) is less costly to investors than VEXRX (0.34). VEXRX is a more actively managed with annual turnover of: 35.00 vs. SASMX (22.00). SASMX has a lower initial minimum investment than VEXRX: SASMX (1000) vs VEXRX (50000). VEXRX annual gain was more profitable for investors over the last year : -12.82 vs. SASMX (-14.81). VEXRX return over 5 years is better than : 15.80 vs. SASMX (-0.41).
SASMXVEXRXSASMX / VEXRX
Total Expense Ratio1.180.34347%
Annual Report Gross Expense Ratio1.180.34347%
Fund Existence27 years23 years-
Gain YTD-14.482-14.72298%
Front Load6%N/A-
Min. Initial Investment1000500002%
Min. Initial Investment IRAN/AN/A-
Net Assets2.05B19.8B10%
Annual Yield % from dividends0.000.56-
Returns for 1 year-14.81-12.82116%
Returns for 3 years-18.35-9.40195%
Returns for 5 years-0.4115.80-3%
Returns for 10 years1.11-1.76-63%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
XBI79.101.46
+1.88%
SPDR® S&P Biotech ETF
CHI9.780.17
+1.77%
Calamos Convertible Opportunities and Income Fund
SBIO28.020.45
+1.63%
ALPS Medical Breakthroughs ETF
BCDF28.540.12
+0.44%
Horizon Kinetics Blockchain Dev ETF
FEP41.67-0.06
-0.14%
First Trust Europe AlphaDEX® ETF